A Proteomic Investigation to Discover Candidate Proteins Involved in Novel Mechanisms of 5-Fluorouracil Resistance in Colorectal Cancer

Mario Ortega Duran,Sadr ul Shaheed,Christopher W. Sutton,Steven D. Shnyder

DOI: https://doi.org/10.3390/cells13040342

IF: 6

2024-02-15

Cells

Abstract:One of the main obstacles to therapeutic success in colorectal cancer (CRC) is the development of acquired resistance to treatment with drugs such as 5-fluorouracil (5-FU). Whilst some resistance mechanisms are well known, it is clear from the stasis in therapy success rate that much is still unknown. Here, a proteomics approach is taken towards identification of candidate proteins using 5-FU-resistant sublines of human CRC cell lines generated in house. Using a multiplexed stable isotope labelling with amino acids in cell culture (SILAC) strategy, 5-FU-resistant and equivalently passaged sensitive cell lines were compared to parent cell lines by growing in Heavy medium with 2D liquid chromatography and Orbitrap FusionTM TribridTM Mass Spectrometry analysis. Among 3003 commonly quantified proteins, six (CD44, APP, NAGLU, CORO7, AGR2, PLSCR1) were found up-regulated, and six (VPS45, RBMS2, RIOK1, RAP1GDS1, POLR3D, CD55) down-regulated. A total of 11 of the 12 proteins have a known association with drug resistance mechanisms or role in CRC oncogenesis. Validation through immunodetection techniques confirmed high expression of CD44 and CD63, two known drug resistance mediators with elevated proteomics expression results. The information revealed by the sensitivity of this method warrants it as an important tool for elaborating the complexity of acquired drug resistance in CRC.

cell biology

What problem does this paper attempt to address?

This paper aims to solve the mechanism problem of colorectal cancer (CRC) developing resistance to the chemotherapeutic drug 5 - Fluorouracil (5 - FU). Although 5 - FU is one of the main adjuvant therapies for advanced colorectal cancer, the overall response rate of patients to it is no more than 15%, mainly because tumor cells can develop a variety of resistance mechanisms. Although some resistance mechanisms are known, such as the increase in the levels of thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD), and the role of multidrug - resistant proteins (such as MDR1), these known mechanisms cannot fully explain why the treatment success rate has not significantly increased in the past three decades. Therefore, this study uses proteomic methods, especially the Stable Isotope Labelling with Amino Acids in Cell Culture (SILAC) technique, to identify candidate proteins that may be involved in 5 - FU resistance, in the hope of discovering new resistance mechanisms.

Specifically, the researchers generated sub - lines of colorectal cancer cell lines resistant to 5 - FU under laboratory conditions and compared them with the parental cell lines. Through the SILAC technique, the researchers were able to quantitatively analyze the changes in protein expression in these cell lines, thereby identifying proteins that were up - regulated or down - regulated in the resistant cell lines. These protein changes may reveal new mechanisms of 5 - FU resistance and contribute to the development of more effective treatment strategies.